Matthew D’MEllow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew D’MEllow has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Jane M. Palmer
Cancer Research Program, QIMR Berghofer, Brisbane, Australia
2 shared publications - Lindsay A. McGrath
Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, Queensland, Australia
2 shared publications - Matthew H. Law
Population Health Department, QIMR Berghofer Medical Research Institute
2 shared publications - Aaron B. Beasley
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia
1 shared publication Antonia L. Pritchard
Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
1 shared publication- Asta Försti
Hopp Children's Cancer Center (KiTZ) Heidelberg Germany
1 shared publication
Latest Publications
- 8 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- p. OF1-OF8
Phenotypic and Genotypic Risk Factors for Uveal Melanoma in a High Ambient UV Radiation Environment
Background: Most evidence on risk factors for uveal melanoma derives from case–control studies prone to recall bias, and its rarity has limited prospective research. To address these gaps, we applied a population-based case–control design incorporating polygenic risk scores (PRS) and Mendelian randomization (MR) to explore genetic and phenotypic determinants of uveal melanoma risk. Methods: The study was conducted in Queensland, Australia. Incident uveal melanoma cases diagnosed between 2011 and 2022 were recruited through specialist ocular oncology clinics. Controls were participants in the QSkin Sun and Health Study, a prospective cohort of 43,794 adults 40 to 69 years of age at baseline (2010–2011). Demographic, phenotypic, and sun exposure factors were harmonized across studies. PRSs were calculated for pigmentation traits and nevus characteristics using genome-wide association study (GWAS) datasets, and MR was used to assess potential causal relationships with uveal melanoma risk. Results: Among 485 uveal melanoma cases and 43,724 controls, several phenotypic traits were strongly associated with uveal melanoma risk: male sex, blue or light eye color, inability to tan, freckling, and high nevus density. A family history of cutaneous melanoma and a personal history of keratinocyte cancer were also associated with higher risk. PRS analyses confirmed significant associations for eye color and freckling. MR analyses supported causal relationships between lighter eye color, freckling propensity, and reduced tanning ability and uveal melanoma risk. Conclusions: These findings provide genetic evidence supporting a causal role for pigmentation-related traits in uveal melanoma susceptibility. Impact: This evidence may help refine risk assessment and inform counseling for individuals with suspicious ocular lesions.
- 8 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- p. OF1-OF8
Phenotypic and Genotypic Risk Factors for Uveal Melanoma in a High Ambient UV Radiation Environment
Background: Most evidence on risk factors for uveal melanoma derives from case–control studies prone to recall bias, and its rarity has limited prospective research. To address these gaps, we applied a population-based case–control design incorporating polygenic risk scores (PRS) and Mendelian randomization (MR) to explore genetic and phenotypic determinants of uveal melanoma risk. Methods: The study was conducted in Queensland, Australia. Incident uveal melanoma cases diagnosed between 2011 and 2022 were recruited through specialist ocular oncology clinics. Controls were participants in the QSkin Sun and Health Study, a prospective cohort of 43,794 adults 40 to 69 years of age at baseline (2010–2011). Demographic, phenotypic, and sun exposure factors were harmonized across studies. PRSs were calculated for pigmentation traits and nevus characteristics using genome-wide association study (GWAS) datasets, and MR was used to assess potential causal relationships with uveal melanoma risk. Results: Among 485 uveal melanoma cases and 43,724 controls, several phenotypic traits were strongly associated with uveal melanoma risk: male sex, blue or light eye color, inability to tan, freckling, and high nevus density. A family history of cutaneous melanoma and a personal history of keratinocyte cancer were also associated with higher risk. PRS analyses confirmed significant associations for eye color and freckling. MR analyses supported causal relationships between lighter eye color, freckling propensity, and reduced tanning ability and uveal melanoma risk. Conclusions: These findings provide genetic evidence supporting a causal role for pigmentation-related traits in uveal melanoma susceptibility. Impact: This evidence may help refine risk assessment and inform counseling for individuals with suspicious ocular lesions.
- Open Access
- 16 June 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (6) , 983-991
GWAS meta-analysis provides new insights into uveal melanoma risk
Objective: The aim of this research is to identify germline genetic variants that predispose to uveal melanoma (UM) using data from nine studies involving 5839 individuals with UM (3853 novel) and 349,863 healthy controls. Methods: Five novel UM genome-wide association studies (GWAS) were performed and included for meta-analysis with four previously published UM GWAS. A fixed-effects inverse-variance weighted (IVW) meta-analysis was performed by combining data from these nine UM case-control cohorts. A follow-up transcriptome-wide association study (TWAS) was conducted to identify candidate target genes at UM risk loci. Genetic correlations with melanoma-related phenotypes were measured to elucidate UM’s genetic architecture. Results: We identify nine linkage disequilibrium (LD)-independent loci (three novel) with an IVW P value of less than 5 × 10 −8 . TWAS analysis indicates five potential target genes, including MOB3B , RBAK , and MTSS1 , which have established links to multiple cancer types. We note a significant genetic correlation (rg = 0.31, P = 0.01) between UM and cutaneous melanoma (CM), and a non-significant but consistent correlation with naevus count (rg = 0.25, P = 0.08). Conclusions: This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.
- 16 June 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (6) , 983-991
Open AccessGWAS meta-analysis provides new insights into uveal melanoma risk
Objective: The aim of this research is to identify germline genetic variants that predispose to uveal melanoma (UM) using data from nine studies involving 5839 individuals with UM (3853 novel) and 349,863 healthy controls. Methods: Five novel UM genome-wide association studies (GWAS) were performed and included for meta-analysis with four previously published UM GWAS. A fixed-effects inverse-variance weighted (IVW) meta-analysis was performed by combining data from these nine UM case-control cohorts. A follow-up transcriptome-wide association study (TWAS) was conducted to identify candidate target genes at UM risk loci. Genetic correlations with melanoma-related phenotypes were measured to elucidate UM’s genetic architecture. Results: We identify nine linkage disequilibrium (LD)-independent loci (three novel) with an IVW P value of less than 5 × 10 −8 . TWAS analysis indicates five potential target genes, including MOB3B , RBAK , and MTSS1 , which have established links to multiple cancer types. We note a significant genetic correlation (rg = 0.31, P = 0.01) between UM and cutaneous melanoma (CM), and a non-significant but consistent correlation with naevus count (rg = 0.25, P = 0.08). Conclusions: This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.